TCL Archive Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2 April 17, 1987
TCL Archive ESA Risk Mitigation Strategy Requires Training, Patient Consent, Documentation February 19, 2010